<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="Houston Texas [2], Saint Louis University St. Louis Missouri [3]," exact="George Washington University" post="School of Medicine Washington District of Columbia [4], Premier"/>
 <result pre="Saint Louis University St. Louis Missouri [3], George Washington University" exact="School of Medicine" post="Washington District of Columbia [4], Premier Clinical Research Spokane"/>
 <result pre="formerly DRM04) is a topical anticholinergic approved by the US" exact="Food and Drug Administration" post="(June 2018) for primary axillary hyperhidrosis in patients 9"/>
 <result pre="Revance Therapeutics, Inc. She has received honoraria for consulting with" exact="Allergan" post="and Dermira, Inc. Dr. Green is an investigator for"/>
 <result pre="for consulting for Atacama Therapeutics; Brickell Biotech, Inc.; Biofrontera AG;" exact="Celgene" post="Corporation; Dermira, Inc.; DUSA Pharmaceuticals, Inc.; LEO Pharma, Inc.;"/>
 <result pre="Celgene Corporation; Dermira, Inc.; DUSA Pharmaceuticals, Inc.; LEO Pharma, Inc.;" exact="Novartis" post="Pharmaceuticals Corporation; Promius Pharma; LLC; Regeneron Pharmaceuticals, Inc.; Sanofi;"/>
 <result pre="He received grants/research funding for serving as an investigator for" exact="Abbott Laboratories;" post="Amgen, Inc.; Asana BioSciences; LLC; Brickell Biotech Inc.; Celgene"/>
 <result pre="Abbott Laboratories; Amgen, Inc.; Asana BioSciences; LLC; Brickell Biotech Inc.;" exact="Celgene" post="Corporation; Dermavant Sciences, Inc.; Eli Lilly and Company; LEO"/>
 <result pre="BioSciences; LLC; Brickell Biotech Inc.; Celgene Corporation; Dermavant Sciences, Inc.;" exact="Eli Lilly and Company;" post="LEO Pharma, Inc.; Merck &amp;amp; Company, Inc.; Novartis Pharmaceuticals"/>
 <result pre="Dermavant Sciences, Inc.; Eli Lilly and Company; LEO Pharma, Inc.;" exact="Merck" post="&amp;amp; Company, Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk A/S;"/>
 <result pre="Lilly and Company; LEO Pharma, Inc.; Merck &amp;amp; Company, Inc.;" exact="Novartis" post="Pharmaceuticals Corporation; Novo Nordisk A/S; Ortho Dermatologics, Inc.; Peplin,"/>
 <result pre="LEO Pharma, Inc.; Merck &amp;amp; Company, Inc.; Novartis Pharmaceuticals Corporation;" exact="Novo Nordisk" post="A/S; Ortho Dermatologics, Inc.; Peplin, Inc.; Photocure ASA; Promius"/>
 <result pre="Population. Oral (Late‐Breaker) presented at 75th Annual Meeting of the" exact="American Academy of Dermatology;" post="2017; Orlando, FL. 4 Amir M , Arish A"/>
</results>
